Aliases & Classifications for Motion Sickness

About this section

Aliases & Descriptions for Motion Sickness:

Name: Motion Sickness 10 12 36 35 65
Travel Sickness, Unspecified 10
 
Motion Sickness Nos 10
Travel Sickness 10

Classifications:



External Ids:

Disease Ontology10 DOID:2951
ICD1027 T75.3
ICD9CM29 994.6
MeSH36 D009041
NCIt42 C34824
UMLS65 C0026603

Summaries for Motion Sickness

About this section
MedlinePlus:35 Motion sickness is a common problem in people traveling by car, train, airplanes and especially boats. motion sickness can start suddenly, with a queasy feeling and cold sweats. it can then lead to dizziness and nausea and vomiting. your brain senses movement by getting signals from your inner ears, eyes, muscles and joints. when it gets signals that do not match, you can get motion sickness. for example, down below on a boat, your inner ear senses motion, but your eyes cannot tell you are moving. where you sit can make a difference. the front seat of a car, forward cars of a train, upper deck on a boat or wing seats in a plane may give you a smoother ride. looking out into the distance - instead of trying to read or look at something in the vehicle - can also help. centers for disease control and prevention

MalaCards based summary: Motion Sickness, also known as travel sickness, unspecified, is related to trichinosis and schizophrenia, and has symptoms including abnormality of the nervous system An important gene associated with Motion Sickness is HTR3A (5-Hydroxytryptamine Receptor 3A), and among its related pathways are Selective Serotonin Reuptake Inhibitor Pathway, Pharmacodynamics and Monoamine GPCRs. The drugs diphenhydramine hydrochloride and diphenhydramine have been mentioned in the context of this disorder. Affiliated tissues include brain, eye and breast, and related mouse phenotypes are nervous system and behavior/neurological.

Wikipedia:68 Motion sickness, also known as kinetosis and travel sickness, is a condition in which a disagreement... more...

Related Diseases for Motion Sickness

About this section

Diseases related to Motion Sickness via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 426)
idRelated DiseaseScoreTop Affiliating Genes
1trichinosis30.1HTR2A, HTR3A, HTR7
2schizophrenia29.9ADRA2A, HTR1A, HTR2A, HTR3A, HTR7
3candidiasis29.6FOS, HTR1A, HTR2A, HTR7
4space motion sickness12.7
5thyroiditis10.4
6hepatitis10.4
7hereditary myopathy with lactic acidosis due to iscu deficiency10.4HTR1A, HTR3A
8prostate cancer10.3
9breast cancer10.3
10prostatitis10.3
11tongue cancer10.3HTR1A, HTR2A
12nelson syndrome10.3HTR1A, HTR2A
13obesity10.3
14lymphoma10.3
15uterine corpus adenomatoid tumor10.3HTR1A, HTR2A
16brachial plexus neoplasm10.3HTR1A, HTR2A
17geniculate herpes zoster10.3HTR1A, HTR2A
18megacolon10.3HTR3A, HTR7
19hantavirus pulmonary syndrome10.3HTR1A, HTR2A
20liver leiomyoma10.3HTR2A, HTR7
21hepatocellular carcinoma10.2
22arthritis10.2
23osteomyelitis10.2
24cerebritis10.2
25pancreatitis10.2
26endotheliitis10.2
27coronary thrombosis10.2HTR2A, HTR7
28ovarian mixed germ cell neoplasm10.2HTR1A, HTR2A
29steatorrhea10.2HTR2A, HTR7
30tympanosclerosis10.2HTR2A, HTR7
31marasmus10.2HTR2A, HTR7
32zebra body myopathy10.2HTR2A, HTR3A
33myocardial infarction10.2
34celiac disease10.2
35multiple myeloma10.2
36colitis10.2
37myeloma10.2
38adenocarcinoma10.2
39retinitis10.2
40kidney disease10.2
41neuropathy10.2
42glioma10.2
43gastric pylorus carcinoma10.2HTR2A, HTR7
44lactocele10.2HTR2A, HTR7
45plasmodium malariae malaria10.2HTR1A, HTR2A, HTR3A
46bipolar ll disorder10.2HTR2A, HTR7
47malignant hyperthermia10.1HTR1A, HTR2A, HTR3A
48mental depression10.1HTR1A, HTR2A, HTR3A
49may-hegglin anomaly10.1HTR1A, HTR2A, HTR3A
50encephalomalacia10.1HTR1A, HTR2A, HTR3A

Graphical network of the top 20 diseases related to Motion Sickness:



Diseases related to motion sickness

Symptoms for Motion Sickness

About this section

HPO human phenotypes related to Motion Sickness:

id Description Frequency HPO Source Accession
1 abnormality of the nervous system HP:0000707

Drugs & Therapeutics for Motion Sickness

About this section

Drugs for Motion Sickness (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 123)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
OndansetronapprovedPhase 428599614-02-54595
Synonyms:
(RS)-1,2,3,9-Tetrahydro-9-methyl-3-(2-methylimidazol-1-ylmethyl)carbazol-4-one
1,2,3,9-Tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-4H-carbazol-4-one
103639-04-9 (mono-hydrochloride dihydrate)
108303-49-7
116002-70-1
9-Methyl-3-(2-methyl-imidazol-1-ylmethyl)-1,2,3,9-tetrahydro-carbazol-4-one
9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one
9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one
99614-01-4 (mono-hydrochloride)
99614-02-5
AB00373674
AC1L1IIM
AKOS000599484
Apo-ondansetron
BAS 00717177
BPBio1_001118
BRD-A19736161-001-01-8
BRD-A19736161-003-03-0
BRN 3622981
BSPBio_001016
C07325
C18H19N3O
CBDivE_008994
CHEMBL46
CID4595
CPD001307702
D00456
DB00904
DESMETHYLONDANSETRON
GR 38032
GR 38032X
GR-38032F
GR38032F
HMS2090H16
I06-0687
I06-1329
L000456
 
LS-172305
LS-51878
MolPort-001-944-253
NCI60_022780
Novo-ondansetron
Ondansetron
Ondansetron (JAN/USP/INN)
Ondansetron Hydrochloride
Ondansetron [USAN:INN:BAN]
Ondansetron hydrochloride dihydrate
Ondansetron, (+,-)-Isomer
Oprea1_435466
Oprea1_852372
PHL-ondansetron
PMS-ondansetron
Prestwick0_001058
Prestwick1_001058
Prestwick2_001058
Prestwick3_001058
Ratio-ondansetron
SAM002589958
SN-307
SPBio_002938
STK370548
STOCK4S-10990
Sandoz ondansetron
TL8006071
TimTec1_001750
UNII-4AF302ESOS
ZOFRAN IN PLASTIC CONTAINER
Zofran
Zofran ODT
Zofran ODT (TN)
Zofran odt
Zophren
Zudan
Zuplenz
ondansetron
ondansetron (Zofran)
2
NeostigmineapprovedPhase 48559-99-44456
Synonyms:
(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate
(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate (ester)
114-80-7 (bromide)
3-Trimethylammoniumphenyl N,N-dimethylcarbamate
3-[(dimethylcarbamoyl)oxy]-N,N,N-trimethylanilinium
3-{[(dimethylamino)carbonyl]oxy}-N,N,N-trimethylanilinium
51-60-5 (methyl sulfate)
59-99-4
AB00053807
AC1L1I7G
Ammonium, (m-hydroxyphenyl)trimethyl-, dimethylcarbamate (ester)
BPBio1_000634
BRD-K18922609-004-04-1
BRN 3615946
BSPBio_000576
Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl- (9CI)
Bloxiverz
C07258
CAS-114-80-7
CCRIS 3079
CHEBI:7514
CID4456
D08261
DB01400
DivK1c_000165
DivK1c_000198
Eustigmin
Eustigmine
HMS2089A22
HSDB 3921
IDI1_000165
IDI1_000198
InChI=1/C12H19N2O2/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5/h6-9H,1-5H3/q+1
Intrastigmina
Juvastigmin
KBio1_000165
KBio1_000198
KBio2_001541
KBio2_004109
KBio2_006677
KBioGR_000623
KBioSS_001541
LS-18452
Lopac-N-2001
 
Lopac0_000816
NCGC00015730-01
NCGC00015730-02
NCGC00015730-03
NCGC00015730-04
NCGC00015730-08
NCGC00021658-03
NCGC00163240-01
NEOSTIGMINE
NINDS_000165
NINDS_000198
Neostigmin
Neostigmine (BAN)
Neostigmine [BAN]
Neostigmine methylsulfate
Neostigmine omega
Neostigminum
Prestwick0_000468
Prestwick1_000468
Prestwick2_000468
Prestwick3_000468
Prostigmin
Prostigmin (TN)
Prostigmine
Prozerin
SPBio_001276
SPBio_002515
STL058953
Spectrum2_001278
Spectrum4_000072
Spectrum5_001234
Spectrum_001061
Synstigmin
Syntostigmine
UNII-3982TWQ96G
Vagostigmin
Vagostigmine
ZINC00001792
[3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium
[3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium bromide
[3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium
bmse000762
m-Trimethylammoniumphenyldimethylcarbamate
nchembio.188-comp33
sulfonatooxymethane
3
AtropineapprovedPhase 41155908-99-6, 51-55-8174174
Synonyms:
(+,-)-Tropyl tropate
(+-)-Atropine
(+-)-Hyoscyamine
(+-)-atropine
(+-)-hyoscyamine
(+/-)-Atropine
(+/-)-Hyoscyamine
(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate
(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl (2S)-3-hydroxy-2-phenylpropanoate
(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate
(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate
(3-endo)-8-methyl-8-azabicyclo[3.2.1]octan-3-ol
(3-endo,8-syn)-3-[(3-hydroxy-2-phenylpropanoyl)oxy]-8-methyl-8-azoniabicyclo[3.2.1]octane
(3-exo)-8-methyl-8-azabicyclo[3.2.1]octan-3-ol
(±)-atropine
(±)-hyoscyamine
1-alpha-H,5-alpha-H-Tropan-3-alpha-ol (+-)-tropate (ester)
1-alpha-H,5-alpha-H-Tropan-3-alpha-ol (+-)-tropate (ester) (8CI)
120-29-6
1alphaH,5alphaH-Tropan-3alpha-ol
1alphaH,5alphaH-Tropan-3alpha-ol (+-)-tropate (ester)
1alphaH,5alphaH-Tropan-3beta-ol
2-Phenylhydracrylic acid 3-alpha-tropanyl ester
51-55-8
8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate
8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate
8-Methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropionate
A0132_SIGMA
A2468_SIGMA
AC1L5AX3
AC1Q3XL2
ACon1_000046
AI3-60219
AKOS005137976
ATROPINE
Ambap120-29-6
Anaspaz
Atropair
Atropen
Atropen (TN)
Atropin
Atropin [German]
Atropin-flexiolen
Atropina
Atropina [Italian]
Atropine
Atropine (USP)
Atropine Care
Atropine Sulfate
Atropine Sulfate S.O.P.
Atropine [BAN]
Atropinol
Atropinum
Atropt
Atrosulf
BRD-A27290375-001-01-8
Belladenal
Bellergal-S
Benzeneacetic acid, alpha-(hydroxymethyl)-, (3-endo)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester
C01479
C17H23NO3
CAS-120-29-6
CCRIS 3080
CHEBI:15742
CHEBI:15884
CHEBI:16684
CHEBI:537621
CHEBI:57858
CHEMBL1235490
 
CID174174
CPD001906768
Cytospaz
D00113
DB00572
DB04026
DL-Hyoscyamine
DL-Tropanyl 2-hydroxy-1-phenylpropionate
DL-Tropyl tropate
EINECS 200-104-8
Eyesules
FT-0082634
HMS2089A16
HSDB 2199
Hyoscyamine sulfate
I-Tropine
Isopto Atropine
Isopto-atropine
LS-7203
MEGxp0_001878
MLS000069795
MLS001148094
MLS002695888
Minims
Minims Atropine
MolPort-001-742-593
MolPort-003-986-158
Mydriasine
NCGC00016370-01
NCGC00142514-01
NCGC00142514-03
NP-010662
Neo-Diophen
OR22908
Ocu-Tropine
Protamine & Atropine
SAM002554885
SMR000058248
ST057178
ST057655
T0534
TL8000018
Tropanol
Tropic acid, 3-alpha-tropanyl ester
Tropic acid, ester with tropine
Tropine (+/-)-tropate
Tropine tropate
Tropine, tropate (ester)
Troyl tropate
Urised
[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate
[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate
[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate
a-Tropine
atropinium cation
atropinium(1+)
b eta-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
beta-Phenyl-gamma-oxypropionsaeure-tropyl-ester [German]
beta-Phenyl-gamma-oxypropionsaure-tropyl-ester [German]
bmse000649
d1-hyoscyamine
dl-Hyoscyamine
dl-Tropyltropate
dl-tropyltropate
endo-(+/-)-alpha-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
endo-8-methyl-8-azabicyclo[3.2.1]octan-3-ol
hyoscyamine
nchembio.307-comp21
tropan-3alpha-ol
tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate
tropan-3beta-ol
4
FosaprepitantapprovedPhase 4154172673-20-0219090
Synonyms:
Fosaprepitant dimeglumine
 
Fosaprepitantum
L-758,298
L-758298
5
Histamine PhosphateapprovedPhase 4, Phase 290651-74-165513
Synonyms:
1H-Imidazole-4-ethanamine, phosphate (1:2)
2-Imidazol-4-ylethylamine orthophosphoric acid (1:2)
4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)
4-(2-Aminoethyl)imidazole di-acid phosphate
4-2(2-Aminoethyl)Imidazole-Di-Acid Phosphate
51-74-1
53623-99-7
74-56-6
AC1L23E4
CID65513
D04445
DB00667
EINECS 200-118-4
 
H0147
Histamine Positive Skin Test Control
Histamine Positive skin test control
Histamine acid phosphate
Histamine biphosphate
Histamine dihydrogen phosphate
Histamine diphosphate
Histamine phosphate (1:2)
Histamine phosphate (TN)
Histamine phosphate (USP)
Histamine phosphate [USP]
Histamine positive
Histaminum
LS-78569
UNII-QWB37T4WZZ
6
Aprepitantapproved, investigationalPhase 4154170729-80-3151165, 6918365
Synonyms:
170729-80-3
221350-96-5
3-(((2R,3S)-3-(P-Fluorophenyl)-2-(((alphar)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(2)-1,2,4-triazolin-5-one
3-(((2R,3S)-3-(p-Fluorophenyl)-2-(((alphaR)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-Delta(2)-1,2,4-triazolin-5-one
3-(((2R,3S)-3-(p-Fluorophenyl)-2-(((alphaR)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(sup 2)-1,2,4-triazolin-5-one
5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one
5-[[(2S,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one
5-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-one
AC1L45SL
AC1OCFCG
Aprepitant
Aprepitant (JAN/USAN/INN)
Aprepitant [USAN]
Aprepitantum
Aprépitant
CHEBI:323967
CHEBI:499361
CHEMBL135613
CHEMBL1471
CHEMBL249465
CID11214788
CID11318675
 
CID151165
CID6918365
CID9936947
CID9936948
D02968
DB00673
Emend
Emend (TN)
HMS2090N12
I06-1151
L 754030
L-754030
LS-156477
MK 0869
MK 869
MK-0517
MK-0869
MK-869
MK-869, L-754030, Emend, Aprepitant
MolPort-006-392-367
NCGC00181785-01
ONO-7436
S1189_Selleck
UNII-1NF15YR6UY
7
Fentanylapproved, illicit, investigationalPhase 4705437-38-73345
Synonyms:
1-Phenethyl-4-(N-phenylpropionamido)piperidine
1-Phenethyl-4-N-propionylanilinopiperidine
437-38-7
5-22-08-00049 (Beilstein Handbook Reference)
80832-90-2
990-73-8 (citrate)
AC1L1FQ2
Abstral
Actiq
BIDD:GT0555
BRN 0494484
CHEBI:119915
CHEMBL596
CID3345
D00320
DB00813
Duragesic
Duragesic (TN)
Duragesic-100
Duragesic-12
Duragesic-25
Duragesic-50
Duragesic-75
Durogesic
EINECS 207-113-6
Fentanest
Fentanil
Fentanil [DCIT]
Fentanila
Fentanila [INN-Spanish]
Fentanilo
Fentanyl
Fentanyl (JAN/USAN/INN)
Fentanyl - Novaplus
Fentanyl Citrate
Fentanyl [INN:BAN]
Fentanyl citrate
Fentanyl-100
 
Fentanyl-12
Fentanyl-25
Fentanyl-50
Fentanyl-75
Fentanylum
Fentanylum [INN-Latin]
HSDB 3329
IONSYS
JNS020QD
L001275
LS-124439
Lazanda
Matrifen
MolPort-003-847-369
N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-Phenethyl-4-piperidyl)propionanilide
N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide
N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide
N-Phenethyl-4-(N-propionylanilino)piperidine
N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
NCGC00168252-01
Nasalfent
Oprea1_152073
Oprea1_207148
PDSP1_000860
PDSP2_000846
Pentanyl
Phentanyl
Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)- (9CI)
R 4263
Rapinyl
Sentonil
Sublimase
Sublimaze
Subsys
UNII-UF599785JZ
fentanyl
8
DiphenhydramineapprovedPhase 421258-73-1, 147-24-03100
Synonyms:
147-24-0
147-24-0 (HYDROCHLORIDE)
2-(Benzhydryloxy)-N,N-dimethylethylamine
2-(Benzhydryloxy)-N,N-dimethylethylamine, hydrochloride
2-(Diphenylmethoxy)-N,N-dimethylethylamine
2-(diphenylmethoxy)-N,N-dimethylethanamine
2-Diphenylmethoxy-N,N-dimethylethylamine
2-[(diphenylmethyl)oxy]-N,N-dimethylethanamine
2-benzhydryloxy-N,N-dimethylethanamine
2-benzhydryloxyethyl-N,N-dimethylammonium
2-diphenylmethoxy-N,N-demthylethanamine
2PM
58-73-1
88637-37-0 (citrate (1:1))
AB00053460
AC-13704
AC1L1F65
AKOS003658554
Aleryl
Alledryl
Aller-Med
Allerdryl
Allergan
Allergan B
Allergeval
Allergical
Allergina
Allergival
Allergy
Allergy Relief
Allermax Caplets
Allernix
Amidryl
Antistominum
Antitussive
Antomin
Automin
BENADRYL HCl
BIDD:GT0152
BPBio1_000275
BRD-K47278471-003-05-7
BRN 1914136
BSPBio_000249
BSPBio_002219
Bagodryl
Banophen
Banophen Caplets
Baramine
Beldin
Belix
Ben-allergin
Bena
Benachlor
Benadrin
Benadryl
Benadryl (hydrochloride)
Benadryl Allergy
Benapon
Bendylate
Benhydramin
Benodin
Benodine
Benylan
Benylin
Benzantin
Benzantine
Benzhydramine
Benzhydraminum
Benzhydril
Benzhydroamina
Benzhydryl
Betramin
CAS-147-24-0
CCRIS 1959
CHEBI:127629
CHEBI:4636
CHEMBL657
CID3100
CPD-10890
Childrens Allergy Relief
Childrens Wal-dryl Allergy
Compoz
D00300
DB01075
DB06975
DIPHENHYDRAMINE, ANTISTOMINUM, BENZHYDRAMINE
Dabylen
Debendrin
Dermistina
Dermodrin
Desentol
Diabenyl
Diabylen
Dibendrin
Dibenil
Dibondrin
Difedryl
Difenhidramina
Difenhidramina [INN-Spanish]
Difenhydramin
Difenhydramine
Difenidramina
Difenidramina [Italian]
Dihidral
Dimedrol
Dimedrol base
Dimedrolum
Dimedryl
Dimehydrinate
Dimethylamine benzhydryl ester
Diphamine
Diphantine
Diphen
Diphen Cough
Diphenhist
Diphenhist Captabs
 
Diphenhydramine
Diphenhydramine (JP15/INN)
Diphenhydramine Base
Diphenhydramine HCl
Diphenhydramine Hydrochloride
Diphenhydramine Salicylate
Diphenhydramine [INN:BAN:JAN]
Diphenhydraminum
Diphenhydraminum [INN-Latin]
Diphenylhydramin
Diphenylhydramine
DivK1c_000368
Dobacen
Dormarex 2
Dryistan
Drylistan
Dylamon
EINECS 200-396-7
Etanautine
FAR 90X2
Genahist
HMS2089E06
HSDB 3066
Help I Cant Sleep
Histaprin
Histaxin
Hyadrine
Hydramine
Hyrexin
I14-6749
IDI1_000368
Ibiodral
Insomnal
KBio1_000368
KBio2_001460
KBio2_004028
KBio2_006596
KBio3_001439
KBioGR_001099
KBioSS_001460
L000227
LS-68208
Lopac-D-3630
Lopac0_000377
MLS002222276
Medidryl
Mephadryl
MolPort-001-783-508
N,N-Dimethyl-2-(diphenylmethoxy)-ethylamine hydrochloride
N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine
N-(Benzhydryloksy-etylo)dwumetyloamina
N-(Benzhydryloksy-etylo)dwumetyloamina [Polish]
N-[2-(BENZHYDRYLOXY)ETHYL]-N,N-DIMETHYLAMINE
NCGC00015335-01
NCGC00015335-02
NCGC00015335-03
NCGC00015335-10
NCGC00024414-03
NCGC00024414-04
NCI60_002916
NCI60_022782
NINDS_000368
NSC665800
Nausen
Nervine Nighttime Sleep-Aid
Nightime Sleep Aid
North Antihistamine
Novamina
Nytol QuickCaps
Nytol Quickcaps
Nytol Quickgels
O-Benzhydryldimethylaminoethanol
O-benzhydryldimethylaminoethanol
Oprea1_254625
PM 255
Prestwick0_000065
Prestwick1_000065
Prestwick2_000065
Prestwick3_000065
Probedryl
Restamin
Restamin (TN)
Rigidil
S51
SMR001307259
SPBio_000961
SPBio_002170
STK103720
STOCK2S-94461
Siladryl
Silphen
Sleep-Eze D
Sleep-Eze D Extra Strength
Spectrum2_000961
Spectrum3_000400
Spectrum4_000520
Spectrum5_000915
Spectrum_000980
Syntedril
Syntodril
TL8003758
Twilite Caplets
UNII-8GTS82S83M
Unisom
Unisom Sleepgels Maximum Strength
Zzzquil
Zzzsleep
alpha-(2-Dimethylaminoethoxy)diphenylmethane
beta-Dimethylamino-aethyl-benzhydryl-aether
beta-Dimethylamino-aethyl-benzhydryl-aether [German]
beta-Dimethylaminoethanol diphenylmethyl ether
beta-Dimethylaminoethyl benzhydryl ether
beta-Dimethylaminoethylbenzhydrylether
beta-dimethylaminoethyl benzhydryl ether
diphenhydramine
nchembio747-comp18
β-dimethylaminoethyl benzhydryl ether
9
PromethazineapprovedPhase 421260-87-74927
Synonyms:
(2-Dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine
(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine
(Dimethylamino-2-propyl-10-phenothiazine hydrochloride
10-(2-(Dimethylamino)-2-methylethyl)phenothiazine
10-(2-(Dimethylamino)propyl)phenothiazine
10-(2-Dimethylaminopropyl)phenothiazine
10-[2-(Dimethylamino)propyl]phenothiazine
10-[2-(dimethylamino)Propyl]phenothiazine
10H-Phenothiazine-10-ethanamine, N,N,alpha-trimethyl- (9CI)
10H-Phenothiazine-10-ethanamine, N,N,alpha-trimethyl-, radical ion(1+)
3277 RP
3389 R.p.
38878-40-9
4-27-00-01253 (Beilstein Handbook Reference)
4182 R.p.
60-87-7
73745-50-3
A-91033
AB00053535
AC-15939
AC1L1J92
Antiallersin
Aprobit
Avomine
BPBio1_000744
BRN 0088554
BSPBio_000676
BSPBio_002777
C07404
CCRIS 7056
CHEBI:8461
CHEMBL643
CID4927
Camergan
D00494
DB01069
Dimapp
Dimethylamino-isopropyl-phenthiazin
Dimethylamino-isopropyl-phenthiazin [German]
Diphergan
Diprazin
Diprazine
Diprozin
DivK1c_000005
EINECS 200-489-2
Fargan
Fenazil
Fenetazina
Fenetazine
Genphen
HMS2089E08
HSDB 3173
Hiberna
Histargan
IDI1_000005
Iergigan
InChI=1/C17H20N2S/c1-13(18(2)3)12-19-14-8-4-6-10-16(14)20-17-11-7-5-9-15(17)19/h4-11,13H,12H2,1-3H3
Isophenergan
Isopromethazine
KBio1_000005
KBio2_001348
KBio2_003916
KBio2_006484
KBio3_001997
KBioGR_001697
KBioSS_001348
L000495
LS-264
Lercigan
Lergigan
Lilly 01516
Lilly 1516
Lopac0_000899
Metaryl
MolPort-001-783-684
N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine
N,N,α-trimethyl-10H-phenothiazine-10-ethanamine
N,N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine
N,N-dimethyl-1-phenothiazin-10-ylpropan-2-amine
N,N-dimethyl-1-phenothiazin-10-ylpropan-2-amine hydrochloride
N-(2'-Dimethylamino-2'-methyl)ethylphenothiazine
N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine
 
N-Dimethylamino-2-methylethyl thiodiphenylamine
NCGC00015817-10
NCGC00089735-02
NCGC00089735-03
NCI-C60673
NCI60_001878
NINDS_000005
NSC 30321
NSC30321
Oprea1_758749
PROMETHAZINE (SEE ALSO PROMETHAZINE HYDROCHLORIDE 58-33-3)
Pelpica
Phargan
Phenadoz
Phenargan
Phenergan
Phenerzine
Phenoject-50
Phensedyl
Pilothia
Pilpophen
Pipolphene
Prestwick0_000888
Prestwick1_000888
Prestwick2_000888
Prestwick3_000888
Pro-50
Proazaimine
Proazamine
Procit
Promacot
Promazinamide
Promergan
Promesan
Prometasin
Prometazin
Prometazina
Prometazina [INN-Spanish]
Prometazine
Prometh
Promethacon
Promethaine
Promethazin
Promethazine
Promethazine (JAN/INN)
Promethazine Hydrochloride
Promethazine [INN:BAN]
Promethazine hydrochloride
PromethazineHcl
Promethazinum
Promethazinum [INN-Latin]
Promethegan
Promethiazine
Promezathine
Prorex
Protazine
Prothazin
Prothazine
Provigan
Pyrethia
Pyrethiazine
RP 3277
Remsed
Romergan
Rumergan
SKF 1498
SPBio_000799
SPBio_002895
Sominex
Spectrum2_000840
Spectrum3_001019
Spectrum4_001149
Spectrum5_000977
Spectrum_000868
Tanidil
Thiergan
UNII-FF28EJQ494
Valergine
Vallergine
WLN: T C666 BN ISJ B1Y1&N1&1
WY 509
Zipan-25
promethazine
10
Midazolamapproved, illicitPhase 463559467-70-84192
Synonyms:
4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluoro-phenyl)-1-methyl-, (Z)-2-butenedioate
59467-70-8
8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepin
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5a][1,4]benzodiazepine hydrochloride
8-Chloro-6-(O-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]-benzodiazepine
8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine
AC-18749
AC1L1HMA
BIDD:GT0647
BRN 0625572
Buccolam
C07524
C18H13ClFN3
CHEMBL655
CID4192
D00550
DB00683
DEA No. 2884
Dazolam
Dea No. 2884
Dormicum
 
Dormicum (TN)
EINECS 261-774-5
LS-77780
Midanium
Midazolam
Midazolam (JAN/INN)
Midazolam Base
Midazolam Hcl
Midazolam Hydrochloride
Midazolam [INN:BAN:JAN]
Midazolamum
Midazolamum [INN-Latin]
Midosed
MolPort-003-849-219
NCGC00168254-01
Ro 21-3981
TL8003787
UC429_SIGMA
UNII-R60L0SM5BC
Versed
ZINC00001732
midazolam
nchembio747-comp32
11
Propofolapproved, investigationalPhase 49312078-54-84943
Synonyms:
2, 6-Diisopropylphenol
2,6 Diisopropylphenol
2,6-Bis(1-methylethyl)phenol
2,6-Bis(Isopropyl)-phenol
2,6-DIISOPROPYLPHENOL
2,6-Diisopropyl phenol
2,6-Diisopropylphenol
2,6-bis(1-methylethyl)-phenol
2,6-di(propan-2-yl)phenol
2078-54-8
28449-97-0
4-06-00-03435 (Beilstein Handbook Reference)
50356-15-5
AB00513968
AC-2038
AC1L1J9Y
AC1Q1OUI
AI3-26295
AM-149
Abbott Brand of Propofol
Alpha Brand of Propofol
Ampofol
Aquafol
Astra Brand of Propofol
AstraZeneca Brand of Propofol
BIDD:GT0436
BPBio1_000950
BPBio1_000969
BRD-K82255054-001-03-5
BRN 1866484
BSPBio_000862
Biomol-NT_000248
Braun Brand of Propofol
C07523
C12H18O
CAS-2078-54-8
CCRIS 9000
CHEBI:44915
CHEMBL526
CID4943
CPD-11437
CPD000059151
Curamed Brand of Propofol
D00549
D015742
D0617
D126608
D126608_ALDRICH
DB00818
DDS-04F
Diisopropylphenol
Dipravan
Diprivan
Diprivan (TN)
Diprivan Injectable emulsion
Disoprivan
Disoprofol
EINECS 218-206-6
EU-0100437
Fresenius Brand of Propofol
Fresenius Kabi Brand of Propofol
Fresofol
HMS1570L04
HMS2089O21
HMS2094E17
 
HSDB 7123
ICI 35,868
ICI 35868
ICI-35,868
ICI-35868
ICI35,868
ICI35868
InChI=1/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H
Ivofol
Jsp004266
Juste Brand of Propofol
LS-996
Lopac-D126608
Lopac0_000437
MLS001066348
MLS001335999
MLS002454360
MolPort-001-794-517
NCGC00015389-01
NCGC00015389-02
NCGC00015389-04
NCGC00015389-09
NCGC00091538-01
NCGC00091538-02
NCGC00091538-03
NCGC00091538-04
NCGC00091538-05
NCGC00091538-06
NSC 5105
NSC5105
PFL
Parnell Brand of Propofol
Pisa Brand of Propofol
Prestwick0_000931
Prestwick1_000931
Prestwick2_000931
Prestwick3_000931
Propofol
Propofol (JAN/USAN/INN)
Propofol Abbott
Propofol Fresenius
Propofol IDD-D
Propofol MCT
Propofol Rovi
Propofol [USAN:INN:BAN]
Propofol(2,6-Diisopropylphenol)
Propofol-Lipuro
Propofolum
Propofolum [Latin]
Rapinovet
Recofol
Rovi Brand of Propofol
S01-0189
SAM002264610
SMR000059151
SPBio_003031
SPECTRUM1505022
ST50405911
Schering Brand of Propofol
UNII-YI7VU623SF
W505102_ALDRICH
ZD-0859
ZINC00968303
Zeneca Brand of Propofol
ghl.PD_Mitscher_leg0.558
nchembio.552-comp7
propofol
12
DexmedetomidineapprovedPhase 4470113775-47-668602, 5311068, 56032
Synonyms:
(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-alpha,2,3-trimethylbenzyl)imidazole
(+)-medetomidine
(S)-medetomidine
113775-47-6
4-[(1S)-1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole
4-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
AC1NSJXT
C07450
CHEBI:4466
CHEMBL778
CID5311068
D00514
DEXMEDETOMIDINE
Dexdor (T)
 
Dexmedetomidin
Dexmedetomidina
Dexmedetomidine
Dexmedetomidine (USAN/INN)
Dexmedetomidine Hydrochloride
Dexmedetomidinum
Dexmédétomidine
MPV 1440
MPV-1440
Medetomidina [Spanish]
Medetomidine
Medetomidinum [Latin]
NCGC00025347-01
PRECEDEX
Precedex
Precedex (TN)
Tocris-2023
ZINC04632106
13
substance PinvestigationalPhase 421733507-63-036511, 44359816
Synonyms:
 
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2
14Histamine H1 AntagonistsPhase 4, Phase 2688
15Anti-Anxiety AgentsPhase 41529
16AnestheticsPhase 4, Phase 2, Phase 37385
17Anti-Allergic AgentsPhase 4, Phase 21312
18Histamine AntagonistsPhase 4, Phase 2826
19
histaminePhase 4, Phase 290675614-87-8, 51-45-6774
Synonyms:
.beta.-Imidazolyl-4-ethylamine
1H-Imidazole-4-ethanamine
1H-Imidazole-5-ethanamine
1avn
1qft
2-(1H-Imidazol-4-yl)ethanamine
2-(1H-Imidazol-4-yl)ethylamine
2-(1H-Imidazol-5-yl)ethanamine
2-(1H-Imidazol-5-yl)ethylamine
2-(1H-imidazol-4-yl)ethan-1-amine
2-(1H-imidazol-5-yl)ethanamine
2-(3H-Imidazol-4-yl)-ethylamine
2-(4-Imidazolyl)ethanamine
2-(4-Imidazolyl)ethylamine
2-Imidazol-4-yl-Ethylamine
2-Imidazol-4-ylethylamine
2-[4-Imidazolyl]ethylamine
4-(2-Aminoethyl)-1H-imidazole
4-(2-Aminoethyl)imidazole
4-Imidazoleethylamine
5-Imidazoleethylamine
51-45-6
53290_FLUKA
64422-25-9
924364-91-0
AC-13185
AC1L19ZT
AC1Q54BV
AC1Q54BW
AKOS000274386
ALBB-005968
BCBcMAP01_000250
BSPBio_001117
BSPBio_002124
Bio1_000487
Bio1_000976
Bio1_001465
Bio2_000389
Bio2_000869
C00388
CCRIS 6535
CHEBI:18295
CHEMBL90
CID774
D08040
DivK1c_000308
EINECS 200-100-6
Eramin
Ergamine
Ergotidine
F411C768-A159-4FC0-A195-291A08BB03AA
Free histamine
H7125_SIGMA
HMS1362G19
HMS1792G19
HMS1990G19
HSDB 3338
HSM
Histamine
Histamine (DCF)
Histamine Base
Histamine [USAN]
Histamine, Free Base
Histaminum
 
Histaminum (TN)
IDI1_000308
IDI1_002144
Imidazole-4-ethylamine
Istamina
Istamina [Italian]
KBio1_000308
KBio2_000457
KBio2_001325
KBio2_003025
KBio2_003893
KBio2_005593
KBio2_006461
KBio3_000853
KBio3_000854
KBio3_001344
KBioGR_000457
KBioGR_001580
KBioSS_000457
KBioSS_001325
L-Histamin base
L-Histamine
L-histamine
L000292
LS-75835
Lopac-H-7250
Lopac0_000595
MLS000069447
MolPort-001-785-597
MolPort-002-042-264
NCGC00015513-01
NCGC00015513-08
NCGC00093371-02
NCGC00093371-03
NCGC00093371-04
NCGC00093371-05
NINDS_000308
NSC 33792
NSC33792
SDCCGMLS-0066601.P001
SMP1_000151
SMR000059091
SPBio_000729
ST073926
STK346752
STOCK5S-55669
Spectrum2_000665
Spectrum3_000452
Spectrum4_000960
Spectrum5_000796
Spectrum_000845
Theramine
UNII-820484N8I3
WLN: T5M CNJ D2Z
ZERO/004089
[3H]histamine
b-Imidazolyl-4-ethylamine
beta-Aminoethylglyoxaline
beta-Aminoethylimidazole
beta-Aminothethylglyoxaline
beta-Imidazolyl-4-ethylamine
beta-aminothethylglyoxaline
bmse000744
histamine
nchembio.87-comp54
nchembio714-comp1
20Cholinesterase InhibitorsPhase 4498
21AnalgesicsPhase 49358
22Hypnotics and SedativesPhase 4, Phase 22032
23Dermatologic AgentsPhase 44555
24Gastrointestinal AgentsPhase 4, Phase 26401
25neurokinin APhase 4220
26Cholinergic AgentsPhase 4, Phase 3, Phase 23243
27Antipsychotic AgentsPhase 42130
28AntiemeticsPhase 4, Phase 23213
29AntipruriticsPhase 4619
30Neurokinin-1 Receptor AntagonistsPhase 4185
31Central Nervous System DepressantsPhase 4, Phase 210016
32
SerotoninPhase 4, Phase 1314750-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
33Serotonin AgentsPhase 4, Phase 12668
34Serotonin AntagonistsPhase 41175
35Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 114795
36Psychotropic DrugsPhase 4, Phase 15501
37Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 218510
38Tranquilizing AgentsPhase 43597
39Anesthetics, IntravenousPhase 41943
40Anesthetics, LocalPhase 42347
41Anesthetics, GeneralPhase 42274
42Adrenergic alpha-AgonistsPhase 41300
43Adrenergic AgonistsPhase 42331
44Analgesics, Non-NarcoticPhase 45184
45Adrenergic AgentsPhase 44204
46Adrenergic alpha-2 Receptor AgonistsPhase 4790
47
AcetylcholineexperimentalPhase 368951-84-3187
Synonyms:
ACh
Acetyl choline ion
Acetylcholine Chloride
Acetylcholine cation
 
Acetylcholinium: acetyl-Choline
Choline acetate
Choline acetate (ester)
Miochol E
O-Acetylcholine
acetylcholine chloride
48AbobotulinumtoxinAPhase 3588
49Butylscopolammonium BromidePhase 2, Phase 358
50Muscarinic AntagonistsPhase 2, Phase 3961

Interventional clinical trials:

(show top 50)    (show all 81)
idNameStatusNCT IDPhase
1The Effect of Combining Aprepitant With Ondansetron in High-risk Patients for Postoperative Nausea and VomitingCompletedNCT01897337Phase 4
2Comparison of the Effects of Neostigmine With Sugammadex on Postoperative Nausea and Vomiting.CompletedNCT02286752Phase 4
3Brace Versus Casting in Pediatric Low Risk Ankle FracturesCompletedNCT00132964Phase 4
4Cast Versus Splint in Children With Acceptably Angulated Wrist FracturesCompletedNCT00610220Phase 4
5Long-term Evaluation on Height and Weight in Patients With MPS II Who Started Treatment at < 6 Years of AgeRecruitingNCT02455622Phase 4
6Countermeasures to Reduce Sensorimotor Impairment and Space Motion Sickness Resulting From Altered Gravity LevelsActive, not recruitingNCT02136420Phase 4
7Dexmedetomidine Versus Propofol in the Medical Intensive Care Unit (MICU)Active, not recruitingNCT01059929Phase 4
8Effects of Prismatic Spectacle Lenses on Symptoms of Dizziness, Headache and Anxiety as Caused by Vertical HeterophoriaCompletedNCT00785135Phase 3
9Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving IdursulfaseCompletedNCT00630747Phase 2, Phase 3
10Iduronate-2-sulfatase Enzyme Replacement Therapy in Mucopolysaccharidosis II (MPS II)CompletedNCT00069641Phase 2, Phase 3
11Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) PatientsCompletedNCT00146770Phase 3
12Botox Injection for Lower Extremity Lengthening and Deformity Correction SurgeryCompletedNCT00412035Phase 3
13Remote Ischemic Preconditioning in Primary PCICompletedNCT00435266Phase 2, Phase 3
14Pharmacokinetic and Efficacy Profile Intranasal Scopolamine SprayEnrolling by invitationNCT02155309Phase 2, Phase 3
15The Effect of Gum Chewing on Postoperative IleusNot yet recruitingNCT00879294Phase 3
16Levo Phencynonate Hydrochloride for the Prevention of SeasicknessCompletedNCT02241629Phase 2
17Effects of Transdermal Scopolamine on Occupational PerformanceCompletedNCT00374478Phase 2
18Meclizine as a Potential Smoking Cessation TreatmentCompletedNCT01443858Phase 2
19Phase II Dose-ranging Study of APD421 in PONVCompletedNCT01510704Phase 2
20Dose-ranging Study of APD405 in Post-operative Nausea and Vomiting (PONV)CompletedNCT00895830Phase 2
21Early Directed Physical Therapy in the Management of Mechanically Ventilated Patients in a Medical Intensive Care UnitCompletedNCT00322010Phase 2
22PEAK Study (Physical Exercise and Activity in Kids)CompletedNCT00213187Phase 2
23A Pilot Study on Exercise After Achilles Tendon RuptureCompletedNCT01298024Phase 2
24Effect of Tai Chi Vs. Structured Exercise on Physical Fitness and Stress in Cancer SurvivorsCompletedNCT00246818Phase 2
25Early Versus Delayed Surgery for Infantile EsotropiaRecruitingNCT01166503Phase 1, Phase 2
26CYCLE Pilot Randomized TrialRecruitingNCT02377830Phase 2
27Electroacupuncture for Chronic Neck PainActive, not recruitingNCT00826215Phase 2
28Metal-metal Articulations Versus Standard 28 mm Cementless Total Hip ArthroplastyActive, not recruitingNCT01113762Phase 2
29Promotion of Oesophageal Motility to Prevent Regurgitation and Enhance Nutrition Intake in ICU Patients.Not yet recruitingNCT02515123Phase 2
30Melatonin for Prevention of Delirium in Critically Ill PatientsNot yet recruitingNCT02615340Phase 2
31Verapamil vs. Sertraline for Vestibular Migraine & Chronic Subjective DizzinessCompletedNCT01669304Phase 1
32Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines?CompletedNCT00360282
33Effect of Transcutaneous Vagal Nerve Stimulation on Reducing Visually Induced Motion Sickness in Healthy VolunteersCompletedNCT02177890
34Risk Factors for Post Operative Nausea and Vomiting(PONV) in Patients Underwent Gynecological Operation Under General AnesthesiaCompletedNCT01020201
35Assessment of Cholinergic and Cognitive Function Using Pharmacologic ASL-Perfusion MRICompletedNCT01379001
36Anti Emetic Efficacy of Combination of Ramosetron and Premixture of Naloxone With Patient-controlled AnalgesiaCompletedNCT02416115
37Dose of Early Therapeutic Mobility: Does Type or Frequency Matter?CompletedNCT00999011
38Endotoxin-induced Inflammatory and Behavioral Responses and Predictors of Individual DifferencesCompletedNCT02529592
39Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT01521728
40Comparative Study of QuietCareCompletedNCT01839825
41Study of Safety and Efficacy on Neuromyopathy of Early Standing With the Assistance of Tilt Table in Critically PatientsCompletedNCT02047617
42Morbidity Following the Diagnosis and Treatment of Patients With Breast CancerCompletedNCT00027105
43Clinical Evaluation of a Novel Balance, Vestibular and Oculomotor Assessment ToolCompletedNCT02171312
44Physical Activity to Modify Sequelae and Quality of Life in Childhood Acute Lymphoblastic LeukemiaCompletedNCT00902213
45Effect of Whole Body Vibration Therapy in Children With Juvenile Idiopathic ArthritisCompletedNCT00836394
46Conservative or Operative Treatment of Fractures in the Neck of the 5th Metacarpal BoneCompletedNCT01139528
47Prospective Study for Safety and Efficacy of InSpace™ in Rotator Cuff Tear SubjectsCompletedNCT00916994
48Correlation Between the American Medical Association Guides to the Evaluation of Permanent Impairment and the Medical Outcomes Study 36-Item Short FormCompletedNCT01760551
49Evaluation of a Novel Midstream Urine Collection Technique for Infants in the Emergency DepartmentCompletedNCT02381834
50Right Bundle Branch Block After Surgical Closure of Ventricular Septal DefectCompletedNCT01480908

Search NIH Clinical Center for Motion Sickness

Inferred drug relations via UMLS65/NDF-RT43:


Cochrane evidence based reviews: motion sickness

Genetic Tests for Motion Sickness

About this section

Anatomical Context for Motion Sickness

About this section

MalaCards organs/tissues related to Motion Sickness:

33
Brain, Eye, Breast, Bone, Lung, Heart, Prostate

Animal Models for Motion Sickness or affiliated genes

About this section

MGI Mouse Phenotypes related to Motion Sickness:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00036317.4ADRA2A, AQP1, AVP, FOS, HTR1A, HTR3A
2MP:00053866.6ADRA2A, AQP1, AVP, FOS, HTR1A, HTR2A

Publications for Motion Sickness

About this section

Articles related to Motion Sickness:

(show top 50)    (show all 573)
idTitleAuthorsYear
1
Mildly progressive pulmonary lymphangiectasis diagnosed in a young adult. (24684358)
2014
2
Pure red cell aplasia complicating chronic lymphocytic leukemia: rapid response to high-dose methylprednisolone and rituximab. (23480495)
2013
3
Expression of procaspase 3 and activated caspase 3 and its relevance in hormone-responsive gallbladder carcinoma chemotherapy. (24009453)
2013
4
Effects of a co-treatment with pyruvate and creatine on dendritic spines in rat hippocampus and posterodorsal medial amygdala in a phenylketonuria animal model. (23430365)
2013
5
Large-scale genome-wide association study of Asian population reveals genetic factors in FRMD4A and other loci influencing smoking initiation and nicotine dependence. (22006218)
2012
6
Punctate inner choroidopathy and multifocal choroiditis with panuveitis share haplotypic associations with IL10 and TNF loci. (21357402)
2011
7
Evaluation of esophageal motility and reflux in children treated for congenital diaphragmatic hernia with the use of combined multichannel intraluminal impedance and pH monitoring. (22008321)
2011
8
The right ventricle in Fabry disease: natural history and impact of enzyme replacement therapy. (20965976)
2010
9
Meta-analysis of factor V Leiden and ischemic stroke in young adults: the importance of case ascertainment. (20616326)
2010
10
The effect of whole grain wheat sourdough bread consumption on serum lipids in healthy normoglycemic/normoinsulinemic and hyperglycemic/hyperinsulinemic adults depends on presence of the APOE E3/E3 genotype: a randomized controlled trial. (20444273)
2010
11
Cerebral amyloid angiopathy and microhemorrhages after amyloid beta vaccination: case report and brief review. (20569670)
2010
12
Intramuscular hemangioma of the temporalis muscle with incidental finding of bilateral symmetric calcification of the basal ganglia: a case report. (20951361)
2010
13
Late onset glycogen storage disease type II with reducing body-like inclusions. (20040332)
2010
14
The t-SNAREs syntaxin4 and SNAP23 but not v-SNARE VAMP2 are indispensable to tether GLUT4 vesicles at the plasma membrane in adipocyte. (20006577)
2010
15
Suppression of nonsense mutations in Rett syndrome by aminoglycoside antibiotics. (19190538)
2009
16
Antigen-specific ANCA ELISAs have different sensitivities for active and treated vasculitis and for nonvasculitic disease. (18089488)
2008
17
Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. (18406051)
2008
18
Basil extract inhibits the sulfotransferase mediated formation of DNA adducts of the procarcinogen 1'-hydroxyestragole by rat and human liver S9 homogenates and in HepG2 human hepatoma cells. (18433972)
2008
19
VISA-P score for patellar tendinopathy in males: adaptation to Italian. (18720116)
2008
20
Phenotypic heterogeneity in a family with FAP due to a TTR Leu58Arg mutation: a clinicopathologic study. (17466336)
2007
21
Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. (16601269)
2006
22
Aldehyde oxidase 1 is highly abundant in hepatic steatosis and is downregulated by adiponectin and fenofibric acid in hepatocytes in vitro. (17022944)
2006
23
Resection of a granular cell tumor of the larynx followed by medialization laryngoplasty with bipedicled sternohyoid muscle transposition. (17141103)
2006
24
Life-threatening bleeding in a patient with a lupus inhibitor and probable acquired factor VII deficiency. (17102654)
2006
25
Par-4-mediated recruitment of Amida to the actin cytoskeleton leads to the induction of apoptosis. (16229834)
2005
26
Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study. (15978304)
2005
27
Imaging Erg and Jun transcription factor interaction in living cells using fluorescence resonance energy transfer analyses. (15922298)
2005
28
HLA-A*2626, a new allele identified through external proficiency- testing exercise. (16185330)
2005
29
Increased incidence of carotid artery wall changes and associated variables in hemodialysis patients without symptomatic cardiovascular disease. (15118996)
2004
30
Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis. (12809841)
2003
31
Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine. (12627520)
2003
32
An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis. (12500238)
2003
33
SHOX mutations. (12424438)
2002
34
Spinocerebellar ataxia type 10: a disease caused by a large ATTCT repeat expansion. (12611436)
2002
35
Stress response to cold in Trichinella species. (12009726)
2001
36
Optic atrophy and chronic acquired polyneuropathy. (10098553)
1999
37
Agalactosyl IgG is elevated in patients with active spondyloarthropathy. (10399791)
1999
38
Detection of an endogenous cannabimimetic molecule, 2-arachidonoylglycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: is 2-arachidonoylglycerol a possible vasomodulator? (9501013)
1998
39
Delorme's operation and sphincteroplasty for rectal prolapse and fecal incontinence. (9870165)
1998
40
Neurochemical organization of the macaque striate cortex: correlation of cytochrome oxidase with Na+K+ATPase, NADPH-diaphorase, nitric oxide synthase, and N-methyl-D-aspartate receptor subunit 1. (9502244)
1998
41
Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the QuAcbec cardiovascular study. (8759066)
1996
42
Calcineurin activity is only partially inhibited in leukocytes of cyclosporine-treated patients. (7770925)
1995
43
Relationship of the renin-angiotensin system and systemic arterial pressure to sodium excretion during atrial natriuretic peptide infusion in men. (1457079)
1992
44
Acute mountain sickness and acetazolamide. (3399193)
1988
45
Ulcerative balanoposthitis associated with non-syphilitic spirochaetal infection. (3949350)
1986
46
Juvenile nephronophthisis associated with retinal pigmentary dystrophy, cerebellar ataxia, and skeletal abnormalities. (1008585)
1976
47
Pulmonary alveolar microlithiasis in two siblings from Iraq. (4729865)
1973
48
PIGMENTED BASAL CELL CARCINOMA. (14062633)
1963
49
50

Variations for Motion Sickness

About this section

Expression for genes affiliated with Motion Sickness

About this section
Search GEO for disease gene expression data for Motion Sickness.

Pathways for genes affiliated with Motion Sickness

About this section

GO Terms for genes affiliated with Motion Sickness

About this section

Biological processes related to Motion Sickness according to GeneCards Suite gene sharing:

(show all 8)
idNameGO IDScoreTop Affiliating Genes
1regulation of hormone secretionGO:004688310.3HTR1A, HTR2A
2smooth muscle contractionGO:00069399.9HTR2A, HTR7
3cellular response to hormone stimulusGO:00328709.8ADRA2A, FOS
4renal water homeostasisGO:00030919.7AQP1, AVP
5water transportGO:00068339.7AQP1, AVP
6female pregnancyGO:00075659.6ADRA2A, FOS
7G-protein coupled receptor signaling pathwayGO:00071868.9ADRA2A, HTR1A, HTR2A, HTR7
8response to drugGO:00424938.9AQP1, FOS, HTR2A

Sources for Motion Sickness

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet